New method offers 80 percent accuracy, researchers say
by pancreaticgary on Sat Sep 13, 2008 12:00 AM
1 1/2 weeks ago I began my 20th Cycle (28 day/cycle) of RAD001. The Phase 2 Trial I was on has ended but I am continuing on the RAD.
Still feeling good and very fortunate.
Gary Lombardi- New Hampshire, Non -operable Non-functioning Islet Cell Pancreatic Cancer with Mets to the liver, dx March 2006. Temodar chemo for 6 months prior to entering drug trial.
When you track a discussion, you will get notified by e-mail if anyone else posts a new message on this discussion. Are you sure you want to track this discussion?
If you stop tracking this discussion, you will no longer get notified by e-mail if anyone else posts a new message on this discussion. Are you sure you want to stop tracking this discussion?
If you were considering traveling for cancer treatment, which headline would you find more interesting?
Destination: HOPE. Cancer care that is worth the trip.
Over 84% of our patients travel to our hospital from another state
Neither headline is interesting
We care about your feedback. Let us know how we can improve your CancerCompass experience.